Sale!

Triglyceride Mix for Interference Testing

$495.00 $295.00

Catalog #: C2010001 (1 mL at 1000 mg/mL )

A mixture of five saturated triglycerides that can be used for interference studies, assaying or chromatography. Mixture consists of 20% (m/m) Triacetin (C2:0), 20% (m/m) Tributyrin (C4:0), 20% (m/m) Tricaproin (C6:0), 20% (m/m) Tricaprylin (C8:0) and 20% (m/m) Tricaprin (C10:0). Available in neat solution of 1000 mg/mL (1 mL).

Live Enquiry about this product via Text/SMS: 1-858-900-3210 (8 am – 8 pm PST)

In stock

SKU: C2010001 Categories: , , , Tags: ,

Description

Triglyceride mix for Interference Testing

Product Data Sheet
Catalog # C2010001
Size 1000 mg (1 mL at 1000 mg/mL)
Other Names Triacylglycerols mix, triglycerides mix, triglycerides
Storage -20C
Concentration Neat
Purity >95%
Storage -20°C. Avoid repeated freeze/thaw cycles.
Supplied as Liquid neat solution
Buffer n/a
Keywords Triglycerides, interference, endogenous substances, Triacetin, Tributyrin, Tricaproin, Tricaprylin, Tricaprin

 

References Related to Triglyceride Mix

  • Gotto, A. M., and Paoletti, R. (1991). Triglycerides: the role in diabetes and atherosclerosis. New York: Raven Press.
  • Araujo, C., and Perez, D. (2013). Triglycerides: chemical structure, biosynthesis and role in disease. New York: Nova Science Publishers.
  • Geeraert, E., and Schepper, D. D. (1983). Structure elucidation of triglycerides by chromatographic techniques. Part 2: RP HPLC of triglycerides and brominated triglycerides. Journal of High Resolution Chromatography, 6(3), 123–132.
  • Medeiros, D. M., and Wildman, R. E. C. (2015). Advanced human nutrition. Burlington, MA: Jones & Bartlett Learning.
  • Gotto, A. M., and Paoletti, R. (1991). Triglycerides: the role in diabetes and atherosclerosis. New York: Raven Press.
  • Gilles A, Frechin L, Natchiar K, Biondani G, Loeffelholz OV, Holvec S, Malaval JL, Winum JY, Klaholz BP, Peyron JF. Targeting the Human 80S Ribosome in Cancer: From Structure to Function and Drug Design for Innovative Adjuvant Therapeutic Strategies. Cells. 2020 Mar 5;9(3). pii: E629.
  • EP07: Interference Testing in Clinical Chemistry. (2020). Retrieved from https://clsi.org/standards/products/method-evaluation/documents/ep07/.
  • Gilles A, Frechin L, Natchiar K, Biondani G, Loeffelholz OV, Holvec S, Malaval JL, Winum JY, Klaholz BP, Peyron JF. Targeting the Human 80S Ribosome in Cancer: From Structure to Function and Drug Design for Innovative Adjuvant Therapeutic Strategies. Cells. 2020 Mar 5;9(3). pii: E629.
  • Coussens NP, Auld D, Roby P, Walsh J, Baell JB, Kales S, Hadian K, Dahlin JL. Compound-Mediated Assay Interferences in Homogenous Proximity Assays. Assay Guidance Manual [Internet]. Bethesda (MD): Eli Lilly & Company and the National Center for Advancing Translational Sciences; 2004-.
    2020 Feb 1.

Related Products